Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leukocyte population profiling in psoriasis patients treated with efalizumab
2008-004721-41Phase 4Active
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Sep 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of efalizumab in psoriasis, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Psoriasis Area and Severity Index. Started Sep 2008; status: active.
02
Drugs
efalizumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2008-004721-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004721-41.